Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gore

Showing results (161-170 of 306) with videos related to

Pageof 31
Sort By:
Blood Cancer Journal|June 13, 2018
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Amer M Zeidan, Maximilian Stahl, Michelle DeVeaux, et al.
Blood|December 21, 2017
Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantationAmer M Zeidan, Maximilian Stahl, Xin Hu, et al.
Leukemia & Lymphoma|July 31, 1998
Topoisomerase II and the response to antileukemic therapyS H Kaufmann, S D Gore, C B Miller, et al.
Blood Reviews|November 20, 2020
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolvedRory M Shallis, Robert P Gale, Hillard M Lazarus, et al.
Cancer|February 26, 2016
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national databaseSean A Fletcher, Angel M Cronin, Amer M Zeidan, et al.
The Journal of Trauma|July 1, 1986
The quality of life after major thermal injury in children: an analysis of 12 survivors with greater than or equal to 80% total body, 70% third-degree burnsD N Herndon, J LeMaster, S Beard, et al.
Journal of Synchrotron Radiation|June 23, 2010
Fast-scanning high-flux microprobe for biological X-ray fluorescence microscopy and microXASR A Barrea, D Gore, N Kujala, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2019
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's LymphomaScott F Huntington, Jessica R Hoag, Rong Wang, et al.
Leukemia & Lymphoma|December 28, 2019
Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study<sup>†</sup>Amy J Davidoff, Xin Hu, Jan Philipp Bewersdorf, et al.
Cancer|June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based studyAmer M Zeidan, Xin Hu, Jessica B Long, et al.
Pageof 31

Showing results (161-170 of 306) with videos related to

Sort By:
Pageof 31
Blood Cancer Journal|June 13, 2018
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Amer M Zeidan, Maximilian Stahl, Michelle DeVeaux, et al.
Blood|December 21, 2017
Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantationAmer M Zeidan, Maximilian Stahl, Xin Hu, et al.
Leukemia & Lymphoma|July 31, 1998
Topoisomerase II and the response to antileukemic therapyS H Kaufmann, S D Gore, C B Miller, et al.
Blood Reviews|November 20, 2020
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolvedRory M Shallis, Robert P Gale, Hillard M Lazarus, et al.
Cancer|February 26, 2016
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national databaseSean A Fletcher, Angel M Cronin, Amer M Zeidan, et al.
The Journal of Trauma|July 1, 1986
The quality of life after major thermal injury in children: an analysis of 12 survivors with greater than or equal to 80% total body, 70% third-degree burnsD N Herndon, J LeMaster, S Beard, et al.
Journal of Synchrotron Radiation|June 23, 2010
Fast-scanning high-flux microprobe for biological X-ray fluorescence microscopy and microXASR A Barrea, D Gore, N Kujala, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2019
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's LymphomaScott F Huntington, Jessica R Hoag, Rong Wang, et al.
Leukemia & Lymphoma|December 28, 2019
Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study<sup>†</sup>Amy J Davidoff, Xin Hu, Jan Philipp Bewersdorf, et al.
Cancer|June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based studyAmer M Zeidan, Xin Hu, Jessica B Long, et al.
Pageof 31